SFX by Ex Libris Inc.

Title:	Pneumococcal disease: prospects for a new generation of vaccines
Source:	Science [0036-8075] Siber, G R yr:1994

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Holmes, S J. "Induction of Immunological Memory in Infants Primed with Haemophilus-Influenzae Type-B Conjugate Vaccines." The Journal of infectious diseases 168.3 (1993): 663-671.
description	2.	Webster, J. "An evaluation of emerging vaccines for childhood pneumococcal pneumonia." BMC public health 11.Suppl 3 (2011).
description	3.	Väkeväinen, M. "Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants." The journal of infectious diseases 184.6 (2001): 789-93.
description	4.	Vernacchio, D. "Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease." The Journal of pediatrics (1998): 275-8.
description	5.	Alexander, J. "Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE ®)." Vaccine 22.19 (2004): 2362-2367.
description	6.	"Permeability characteristics of deoxygenated sickle cells." Blood 76.10 (1990): 2139-.
description	7.	Alexander, M. Calling the Shots : Childhood Vaccination - One Family's Journey.
description	8.	Anttila, M. "Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines." The journal of infectious diseases 177.6 (1998): 1614-21.
description	9.	D'Onise K, Raupach JC;, K. "The burden of influenza in healthy children in South Australia." Medical journal of Australia 188.9 (2008): 510-3.
description	10.	Sinha, A. "Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis." Lancet, The 369.9559 (2007): 389-396.
description	11.	Swiatlo, -Edwin [Author [. "Novel vaccine strategies with protein antigens of Streptococcus pneumoniae." FEMS immunology and medical microbiology 38.1 (2003): 1-7.
description	12.	Margolis, Angela E E. "Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention." Pharmacotherapy 25.9 (2005): 1193-212.
description	13.	Esposito, S. "Pharmacotherapy for pneumococcal infections: an update." Expert opinion on pharmacotherapy 14.1 (2013): 65-77.
description	14.	Lode, H. "Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species." International Journal of Antimicrobial Agents 32.3 (2008): 199-206.
description	15.	Prosser, Lisa A A. "Health benefits, risks, and cost-effectiveness of influenza vaccination of children." Emerging infectious diseases 12.10 (2006): 1548-1558.
description	16.	Jin, J. "The level of decoy epitope in PCV2 vaccine affects the neutralizing activity of sera in the immunized animals." Biochemical and biophysical research communications 496.3 (2018): 846-851.
description	17.	Boxus, M. "Antibody avidity measurements in recipients of Cervarix vaccine following a two-dose schedule or a three-dose schedule." Vaccine 32.26 (2014): 3232-3236.
description	18.	Kinjo, Y. "The role of invariant natural killer T cells in microbial immunity." Journal of infection and chemotherapy 19.4 (2013): 560-570.
description	19.	2012.
description	20.	Tarbet, James B. "Vaccine production training to develop the workforce of foreign institutions supported by the BARDA influenza vaccine capacity building program." Vaccine 31.12 (2012): 1646-1649.